BMS Accuses Teva Of Infringing Eliquis Blood Thinner Patent
A Bristol-Myers Squibb subsidiary has fought back against Teva Pharmaceuticals' bid to invalidate the European patent for its blockbuster blood thinner, rejecting the generic drugmaker's claim that it did little more...To view the full article, register now.
Already a subscriber? Click here to view full article